drugset / Trial / NCT01993420
A Safety and Efficacy of DRM02 in Subjects With Atopic Dermatitis
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether DRM02 is safe and effective in the treatment of atopic dermatitis when applied twice daily for 6 weeks.
Timeline
- Start
- 2013-10
- Primary completion
- 2014-02
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DRM02 | Unknown | 0.25 % | Topical |